Browsing Category
Pharmaceutical
AstraZeneca Faces Double Blow as Stock Plummets
AstraZeneca, one of the world's leading pharmaceutical companies, experienced a significant setback on Tuesday as its stock price plummeted, wiping out £15 billion in market value. This dramatic drop was triggered by a combination of…
Exercise Pills Could Transform Healthcare Investment Landscape As Danish Research Shows Promise
Recent breakthrough research from Denmark's Aarhus University has sparked significant market interest in the pharmaceutical sector, particularly concerning exercise mimetics. The discovery of LaKe, a compound purported to replicate the…
Cancer Cases Among Under 50s Double as Scientists Launch Global Study
A concerning trend in cancer diagnoses among young adults has sparked a significant £20 million global research initiative. Data from the UK reveals cancer cases in individuals under 50 are rising at twice the rate compared to elderly…
GSK Maintains Annual Forecast Despite Vaccine Division Setback as New Drug Portfolio Shows Promise
British pharmaceutical giant GSK has held firm on its annual group forecasts despite experiencing a decline in vaccine sales, with strong performance in specialist medicines helping to offset the downturn. The FTSE 100 company reported a 2%…
Groundbreaking Three Drug Treatment for Advanced Breast Cancer Doubles Patient Survival Rates
A revolutionary combination of three drugs has demonstrated remarkable success in doubling survival times for patients battling incurable breast cancer, according to a landmark clinical trial. The research, spearheaded by the Institute of…
France warns US Sanofi buyer about penalties for moving production abroad
The French government warned a US-based private equity firm that was buying the consumer healthcare division of Sanofi, that it would face penalties exceeding EUR100m for not keeping production and jobs in France.
Sanofi is separating…
AstraZeneca Faces Scrutiny as Chinese Authorities Detain Staff
In a significant development for the pharmaceutical giant AstraZeneca, Chinese authorities have reportedly detained five current and former employees as part of an investigation into potential breaches of data privacy and import…
Unregulated Antibiotic Use in Animal Research Poses Threat to Human Health Study Finds
A recent study has highlighted concerning practices in animal research facilities that may worsen the global crisis of antimicrobial resistance. Published in the journal *Plos One*, the research indicates that antibiotic use in laboratory…
Revolutionary Weight Loss Jabs Have The Potential To Treat Cancer, Arthritis, Alzheimer’s, and…
The pharmaceutical industry stands on the cusp of a major transformation as revolutionary weight-loss injections demonstrate potential far beyond their initial scope. Semaglutide, marketed under brands like Ozempic and Wegovy, has shown…
GSK and Other Drugmakers Granted Hearing in Zantac Cancer Litigation Case
The Delaware Supreme Court has agreed to hear an appeal by GSK and other pharmaceutical giants, including Pfizer, Sanofi, and Boehringer Ingelheim, in their bid to halt more than 70,000 lawsuits alleging that the discontinued heartburn…
Adaptive Deep Brain Stimulation Offers Hope for Better Parkinson’s Symptom Control
In a groundbreaking pilot study, researchers have introduced an innovative approach to deep brain stimulation (DBS) that may greatly enhance the lives of individuals with Parkinson's disease. This technique, referred to as "adaptive" DBS,…
AI Revolutionises Drug Discovery Saving Time and Lives for Pharmaceutical Giants
In a world where numerous industries are reevaluating the transformative potential of artificial intelligence (AI), the pharmaceutical sector is already experiencing revolutionary changes in drug discovery. Companies like GSK and…
AstraZenecas 450M Pound Vaccine Plant Investment at Risk Amid Treasury Budget Cuts
The fate of AstraZeneca's planned £450 million investment in a vaccine manufacturing facility in northwest England hangs in the balance as the Treasury, under the leadership of Chancellor Rachel Reeves, reviews spending decisions made by…
NHS Launches Antibiotic Subscription Scheme with Pharmaceutical Industry
The National Health Service (NHS) has announced a groundbreaking initiative to tackle the growing threat of antimicrobial resistance (AMR) by partnering with the pharmaceutical industry. The NHS will negotiate fixed-fee contracts with…
Pfizer continues to test a once-aday weight loss pill
A pharmaceutical giant will test an experimental treatment in response to the surge in demand for obesity treatments
Pfizer has accelerated the trials of a weight loss pill that can be taken once a day. Drug makers are racing to create…
Arecor Therapeutics PLC: A Rising Star in Diabetes and Obesity Innovations
Arecor Therapeutics PLC, listed on AIM as AREC, has been making waves in the healthcare industry with its innovative approach to diabetes and obesity treatments. In a recent interview with Proactive Investor's Stephen Gunnion, CEO Sarah…
After Macron’s charm offensive, UK pharmaceutical giants commit £430m to France
After Emmanuel Macron's charm offensive, the two largest pharmaceutical companies in Britain have committed £430m to France.
AstraZeneca, GSK and other pharmaceutical companies have pledged to upgrade their facilities within the country…
FDA Grants Rare Pediatric Disease Designation to Imaging Biometrics’ Lead Drug Candidate…
Imaging Biometrics, a subsidiary of IQ-AI Ltd, has recently made a significant announcement regarding its lead drug candidate, IB-003. The US Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to…